Profil
Bruce Sargeant is the founder who holds the position of Chief Executive Officer at Fusion Biotec, Inc. which is founded in 2016.
Postes actifs de Bruce Sargeant
| Sociétés | Poste | Début |
|---|---|---|
Fusion Biotec, Inc.
 Fusion Biotec, Inc. Medical SpecialtiesHealth Technology Part of Veranex, Inc., Fusion Biotec, Inc. is a contract engineering and manufacturing firm based in Orange, CA, dedicated to the diagnostics and medical device industry. The company brings together art, science, and engineering to create world-class medical devices, providing best-practice processes in the medical industry to the designs that drive commercial success. The company's strategy is to create and execute elegant, ingenious, and cost-conscious designs. Fusion Biotec is ISO 13485 certified for development and manufacturing, FDA and FDB registered. The company was founded in 2016 by Bruce Sargeant, Michael White, Dave Hines, Ross Dehmoobed, Steve Maylish. Bruce Sargeant has been the CEO since 2016. Fusion Biotec was acquired by Veranex, Inc. on December 13, 2022. | Directeur Général | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Fusion Biotec, Inc.
Fusion Biotec, Inc. Medical SpecialtiesHealth Technology Part of Veranex, Inc., Fusion Biotec, Inc. is a contract engineering and manufacturing firm based in Orange, CA, dedicated to the diagnostics and medical device industry. The company brings together art, science, and engineering to create world-class medical devices, providing best-practice processes in the medical industry to the designs that drive commercial success. The company's strategy is to create and execute elegant, ingenious, and cost-conscious designs. Fusion Biotec is ISO 13485 certified for development and manufacturing, FDA and FDB registered. The company was founded in 2016 by Bruce Sargeant, Michael White, Dave Hines, Ross Dehmoobed, Steve Maylish. Bruce Sargeant has been the CEO since 2016. Fusion Biotec was acquired by Veranex, Inc. on December 13, 2022. | Health Technology |
